RIM
RS Investment Management Portfolio holdings
AUM
$9.73B
Turnover
26.94%
1-Year Est. Return
3.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+3.24%
3 Year Est. Return
+50.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.73B
AUM Growth
-$385M
(-3.8%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
14.92%
Holding
438
New
62
Increased
134
Reduced
162
Closed
56
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kirby Corp
KEX
|
+$55M |
| 2 |
Integra LifeSciences
IART
|
+$51.1M |
| 3 |
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$45.4M |
| 4 |
WBMD
WebMD Health Corp.
WBMD
|
+$43.4M |
| 5 |
Ingevity
NGVT
|
+$39.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Myriad Genetics
MYGN
|
+$81.5M |
| 2 |
Steris
STE
|
+$57.7M |
| 3 |
Red Robin
RRGB
|
+$56.8M |
| 4 |
Dollar General
DG
|
+$52.6M |
| 5 |
Zebra Technologies
ZBRA
|
+$48.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Healthcare | 15.94% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 13.08% |
| 5 | Industrials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PF
1
DELISTED
Pinnacle Foods, Inc.
PF
| $233M | 2.39% |
5,031,313
+105,936
| +2% | +$4.61M |
2014 Q2
8 quarters
|
|
|
LOGM
2
DELISTED
LogMein, Inc.
LOGM
| $159M | 1.64% |
2,511,281
-415,065
| -14% | -$24M |
2013 Q3
11 quarters
|
|
3
Progressive
PGR
$124B
| $154M | 1.58% |
4,593,043
+177,602
| +4% | +$5.88M |
2014 Q4
6 quarters
|
|
4
DELISTED
Ultimate Software Group Inc
ULTI
| $136M | 1.4% |
647,288
-18,500
| -3% | -$3.67M |
2013 Q2
12 quarters
|
|
|
HMSY
5
DELISTED
HMS Holdings Corp.
HMSY
| $134M | 1.37% |
7,591,994
+1,510,011
| +25% | +$24.4M |
2013 Q4
10 quarters
|
|
6
DELISTED
Sealed Air
SEE
| $134M | 1.37% |
2,904,283
+48,140
| +2% | +$2.3M |
2013 Q2
12 quarters
|
|
7
Monolithic Power Systems
MPWR
$61.1B
| $133M | 1.36% |
1,942,637
-153,517
| -7% | -$10.1M |
2014 Q1
9 quarters
|
|
8
Euronet Worldwide
EEFT
$2.39B
| $126M | 1.3% |
1,822,483
+148,594
| +9% | +$11.3M |
2013 Q2
12 quarters
|
|
|
QVCGA
9
DELISTED
QVC Group Inc Series A
QVCGA
| $125M | 1.28% |
101,316
+116
| +0.1% | +$146K |
2013 Q2
12 quarters
|
|
10
DELISTED
Equity Commonwealth
EQC
| $119M | 1.22% |
4,085,905
-785,442
| -16% | -$22.3M |
2014 Q3
7 quarters
|
|
|
AGN
11
DELISTED
Allergan plc
AGN
| $113M | 1.16% |
489,611
+159,021
| +48% | +$36.7M |
2013 Q3
11 quarters
|
|
12
RB Global
RBA
$16.3B
| $109M | 1.12% |
3,226,760
-224,801
| -7% | -$6.96M |
2015 Q1
5 quarters
|
|
13
Ligand Pharmaceuticals
LGND
$5.88B
| $98.4M | 1.01% |
1,322,074
-140,736
| -10% | -$10.4M |
2013 Q3
11 quarters
|
|
|
LVNTA
14
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $96.8M | 1% |
2,612,526
-499,171
| -16% | -$19M |
2014 Q4
6 quarters
|
|
15
Microsoft
MSFT
$3.96T
| $96.1M | 0.99% |
1,878,707
+29,466
| +2% | +$1.53M |
2013 Q2
12 quarters
|
|
16
Agilent Technologies
A
$49.1B
| $95.4M | 0.98% |
2,149,542
-510,784
| -19% | -$22M |
2015 Q3
3 quarters
|
|
17
West Pharmaceutical
WST
$26.4B
| $95.1M | 0.98% |
1,253,102
-333,431
| -21% | -$24.3M |
2013 Q2
12 quarters
|
|
|
PFPT
18
DELISTED
Proofpoint, Inc.
PFPT
| $89.5M | 0.92% |
1,418,156
+7,597
| +0.5% | +$434K |
2013 Q2
12 quarters
|
|
|
BKI
19
DELISTED
Black Knight, Inc. Common Stock
BKI
| $88.4M | 0.91% |
2,351,086
-395,650
| -14% | -$13.1M |
2015 Q2
4 quarters
|
|
20
CVS Health
CVS
$116B
| $86M | 0.88% |
897,935
+105,180
| +13% | +$10.5M |
2013 Q2
12 quarters
|
|
21
Alphabet (Google) Class A
GOOGL
$4.25T
| $84.7M | 0.87% |
2,408,560
+11,400
| +0.5% | +$418K |
2015 Q4
2 quarters
|
|
22
Chevron
CVX
$436B
| $78M | 0.8% |
743,593
+1,670
| +0.2% | +$168K |
2014 Q3
7 quarters
|
|
23
HEICO Corp Class A
HEI.A
$31.4B
| $77.3M | 0.79% |
3,515,649
-1,577,518
| -31% | -$33.3M |
2013 Q2
12 quarters
|
|
24
JPMorgan Chase
JPM
$890B
| $73.9M | 0.76% |
1,189,992
+14,157
| +1% | +$884K |
2013 Q2
12 quarters
|
|
25
Hexcel
HXL
$6.64B
| $73.8M | 0.76% |
1,772,839
-746,262
| -30% | -$32.6M |
2013 Q2
12 quarters
|
|
Similar funds
SG
KGI
VAM
FBNAT
CPS
LH
CPM
VFS
RS Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, RS Investment Management held 438 positions worth $9.73B, down 3.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RS Investment Management withdrew a net $739M in Q2 2016, closing 56 positions and reducing 162 holdings. Its most notable exit was Myriad Genetics, an estimated $81.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, RS Investment Management opened a new position in Kirby Corp worth $52.4M.
- RS Investment Management's largest Q2 2016 buy was Kirby Corp: 839,753 shares worth $52.4M.
- RS Investment Management added most to Allergan plc in Q2 2016, an estimated $36.7M increase.
- RS Investment Management's biggest Q2 2016 reduction was Steris, cutting an estimated $57.7M.
- RS Investment Management fully exited Myriad Genetics in Q2 2016, selling an estimated $81.5M.
- RS Investment Management's ten largest holdings make up 15% of its $9.73B portfolio in Q2 2016.
- RS Investment Management opened 62 new positions and closed 56 in Q2 2016.
- RS Investment Management's portfolio value fell 3.8% quarter-over-quarter to $9.73B.
Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.